Effects of ultrasound treatment on insulin sensitivity in diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates how hepatic ultrasound treatment influences whole-body insulin sensitivity in individuals with Type 2 diabetes. Participants will undergo a series of outpatient ultrasound sessions followed by either an Oral Glucose Tolerance Test (OGTT) or a Hyperinsulinemic-Euglycemic Clamp (HEC) test. The study includes a two-week follow-up observational period with continuous glucose monitoring to assess changes in insulin sensitivity. The aim is to gather data on the effectiveness of ultrasound as a potential treatment for improving insulin sensitivity.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Type 2 diabetic (T2D) subjects must be aged 18-80 and must be able to provide written informed consent
* All subjects must have had T2D for at least 3 months prior to study enrollment. All subjects must be either on diet and exercise or oral antidiabetic agents alone, not on insulin or any form of insulin or GLP-1 receptor agonists.
* Subjects must demonstrate:

  1. A past medical history of abnormal glucose control and carry a diagnosis of T2D according to current ADA criteria:

     * A fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher, or
     * A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test (OGTT), or
     * A random plasma glucose of 200 mg/dL (11.1 mmol/L) or higher in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis or
     * A hemoglobin A1c (HbA1c) level of 6.5% or higher.
  2. Be willing to carry a continuous glucose monitor for at least 10 days.
  3. Be willing to follow all required instructions by study personnel and appear for the required laboratory assessments, including euglycemic clamps and OGTT.

Exclusion Criteria:

* BMI \>40kg/m2.
* Untreated proliferative retinopathy
* Creatinine clearance \< 60 ml/min/1.73 m2.
* Serum creatinine ≥1.5 mg/dL
* Positive pregnancy test, or presently breast-feeding, or failure to follow effective contraceptive measures
* Active infection including hepatitis C, hepatitis B, HIV,
* Any history of Active alcohol abuse
* History of non-adherence to prescribed regimens
* Baseline Hgb \< 10.5 g/dL in females, or \< 13 g/dL in males
* History of coagulopathy or medical condition requiring long-term anticoagulant therapy (low-dose aspirin treatment is allowed)
* Co-existing cardiac disease with active medication titration. Patients on stable meds without active cardiac complications permitted.
* Liver function tests outside of 3xUL of normal range
* GI disorders potentially interfering with the ability to absorb oral medications and h/o upper GI surgery that might have changed anatomy in the target areas.
* Any medical condition or medication that, in the opinion of the investigators, will interfere with the safe completion of the study or study outcomes.

Where it's running

• Yale School of Medicine
  New Haven, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Raimund Herzog, MD, MHS — Yale University
• Study coordinator: Raimund Herzog, MD MHS
• Email: raimund.herzog@yale.edu
• Phone: +1 (203) 737-4773

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improve Teen Sleep to Support Healthy Blood Sugar and Metabolism

  This study tests whether extending and timing teens’ sleep, with melatonin and morning light, can improve insulin sensitivity and energy use in overweight adolescents.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT07618117

• Weekly physiologic insulin sessions to improve insulin sensitivity and memory in Alzheimer’s

  This trial will test whether weekly short (up to two-hour) physiologic insulin sessions can improve how the body uses glucose and help thinking and memory in adults with Alzheimer’s disease.

  Recruiting Pennington Biomedical Research Center · Baton Rouge, Louisiana · NCT07265323

• Colchicine to improve insulin sensitivity in people with type 1 diabetes and low-grade inflammation

  This trial will test whether adding colchicine to usual care can improve insulin sensitivity in adults with type 1 diabetes who have chronic low-grade inflammation.

  Recruiting Phase 2 University Hospital, Gentofte, Copenhagen · Gentofte Municipality · NCT07247734

• Understanding how different meals affect metabolism

  This study tests how different types of meals affect metabolism in young adults to see how their bodies respond to various nutrients.

  Recruiting Instituto Nacional de Medicina Genomica · Mexico City · NCT06878781

• Investigating how exercise affects muscle insulin sensitivity

  This study tests how a single session of one-legged exercise affects how well young healthy men’s muscles respond to insulin.

  Recruiting University of Copenhagen · Copenhagen · NCT06776094

• Effects of Lipids on Health in Night Shift Workers

  This study is testing how certain fats in the body affect heart health and blood sugar in people who work night shifts, while also trying a new eating schedule to see if it helps.

  Recruiting Colorado State University · Fort Collins, Colorado · NCT06550115

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.